0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessDronedarone is an effective AAD in patients with AF/AFL and CV risk factors across a wide range of renal function.
Máté Vámos, Jonas Oldgren, Gi‐Byoung Nam, Professor Gregory Lip, Hugh Calkins, Jun Zhu, Kwo‐Chang Ueng, Ulf Ludwigs, Mattias Wieloch, John A. Stewart, Stefan H. Hohnloser (2021). Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a<i>post hoc</i>analysis of the ATHENA trial. , 8(4), DOI: https://doi.org/10.1093/ehjcvp/pvab090.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2021
Authors
11
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1093/ehjcvp/pvab090
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
